Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire made its biggest ever acquisition yet in January 2015 with a $5.2 billion deal for US biotechnology company NPS Pharmaceuticals. The move came a few months after the group's sale to rival AbbVie collapsed.
Financial Data
-
31st Dec 17 Source: CRO
- €12.4 billion turnover
-
€3.5 billion
profit - 22,000 employees
-
31st Dec 16 Source: CRO
- €1.6 billion turnover
-
€115.2 million
profit - 109 employees
- 9 more years available »
Ranking
By Turnover
(€12.4 billion)- 10th in Top Companies
- 2nd in Pharma
By Employees
(22,000)- 8th in Top Companies
- 1st in Pharma
-
- 22,000
- €12.4 billion
Employees
- Flemming Ornskov CEO/Managing Director
Latest News
- 4:25am Doyle hotels report no adverse impact from Brexit
- 4:15am Just 33 affordable mortgages drawn down in Dublin city
- 4:00am France faces growing threat of skills shortages
- 2:25am Government had ‘open door’ policy towards NBP bidder, TD claims
- 1:00am Some retirees facing mandatory higher pension drawdowns